PER 3.57% 8.7¢ percheron therapeutics limited

Sarepta has far too much Debt !Anp will not follow in their...

  1. 13,207 Posts.
    lightbulb Created with Sketch. 1398
    Sarepta has far too much Debt !
    Anp will not follow in their footsteps
    Also Sarepta has only 17% of DMD ambulant boys ( yet to provide FDA with efficacy data )
    The point being Boomy
    Anti inflammation drug in combination with a multitude of diseases is a much bigger market .
    Just in the US by 2030 $10 billion for DMD
    Limb Girdle $2 billion
    Asthma $21 billion
    MS $$$?
    whether you like it or not Sarepta is a pathetic comparison:
    Sorry dude






 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.003(3.57%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.